NasdaqGM - Nasdaq Real Time Price USD
Immuneering Corporation (IMRX)
1.9600
-0.1600
(-7.55%)
At close: June 12 at 4:00:01 PM EDT
1.9300
-0.03
(-1.53%)
Pre-Market: 9:12:16 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.38 | -0.41 | -1.6 | -1.64 |
| Low Estimate | -0.45 | -0.5 | -2.11 | -2.34 |
| High Estimate | -0.3 | -0.34 | -1.36 | -0.54 |
| Year Ago EPS | -0.47 | -0.49 | -2.04 | -1.6 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.53 | -0.55 | -0.44 | -0.58 |
| EPS Actual | -0.47 | -0.49 | -0.58 | -0.42 |
| Difference | 0.06 | 0.06 | -0.13 | 0.16 |
| Surprise % | 10.76% | 11.18% | -30.34% | 28.21% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.38 | -0.41 | -1.6 | -1.64 |
| 7 Days Ago | -0.38 | -0.41 | -1.6 | -1.48 |
| 30 Days Ago | -0.43 | -0.44 | -1.6 | -1.48 |
| 60 Days Ago | -0.46 | -0.47 | -1.95 | -1.82 |
| 90 Days Ago | -0.41 | -0.43 | -1.54 | -1.81 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | 2 | 1 |
| Up Last 30 Days | 2 | 2 | 2 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IMRX | 19.68% | 16.84% | 21.45% | -2.18% |
| S&P 500 | 13.13% | 2.45% | 7.55% | 14.06% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 6/5/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 5/7/2025 |
| Maintains | Chardan Capital: Buy to Buy | 5/6/2025 |
| Reiterates | Needham: Buy to Buy | 4/10/2025 |
| Maintains | Chardan Capital: Buy to Buy | 3/24/2025 |
| Reiterates | Needham: Buy to Buy | 3/21/2025 |
Related Tickers
JSPR Jasper Therapeutics, Inc.
5.57
-0.54%
VTYX Ventyx Biosciences, Inc.
2.4900
+2.05%
SPRB Spruce Biosciences, Inc.
0.0780
+27.87%
RVMD Revolution Medicines, Inc.
41.11
+0.78%
XLO Xilio Therapeutics, Inc.
0.6836
-0.19%
ORIC ORIC Pharmaceuticals, Inc.
9.67
+2.98%
TYRA Tyra Biosciences, Inc.
10.33
+1.47%
CLYM Climb Bio, Inc.
1.2800
+1.59%
TSHA Taysha Gene Therapies, Inc.
2.6500
-0.75%
ELEV Elevation Oncology, Inc.
0.3802
+0.18%